Serum calcium and breast cancer risk: Results from a prospective cohort study of 7,847 women

Cancer Causes and Control

Volumn 18, Issue 6, 2007, Pages 595-602

  Almquist, Martin ^a   Manjer, Jonas ^a   Bondeson, Lennart ^a   Bondeson, Anne Greth ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Calcium; Obesity; Parathyroid hormone; Vitamin D

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HUMAN; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE; PREMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; VITAMIN BLOOD LEVEL;

BODY MASS INDEX; BREAST NEOPLASMS; CALCIUM; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OBESITY; PARATHYROID HORMONE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D;

EID: 34249999393     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-007-9001-0     Document Type: Article

References (45)

1. McGrath CM, Soule HD (1984) Calcium regulation of normal human mammary epithelial cell growth in culture. In Vitro 208:652-662
2. Russo J, Mills MJ, Moussalli MJ, Russo IH (1989) Influence of human breast development on the growth properties of primary cultures. In Vitro Cell Dev Biol 257:643-649
3. VanHouten JN (2005) Calcium sensing by the mammary gland. J Mammary Gland Biol Neoplasia 102:129-139
4. Moorman PG, Terry PD (2004) Consumption of dairy products and the risk of breast cancer: a review of the literature. Am J Clin Nutr 801:5-14
5. McCarty MF (2000) Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses 543:475-482
6. Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 162:83-95
7. Carmeliet G, Van Cromphaut S, Daci E, Maes C, Bouillon R (2003) Disorders of calcium homeostasis. Best Pract Res Clin Endocrinol Metab 174:529-546
8. Birch MA, Carron JA, Scott M, Fraser WD, Gallagher JA (1995) Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines. Br J Cancer 721:90-95
9. Linforth R, Anderson N, Hoey R et al (2002) Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival. Clin Cancer Res 810:3172-3177
10. Hoey RP, Sanderson C, Iddon J et al (2003) The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells. Br J Cancer 884:567-573
11. Palmer M, Adami HO, Krusemo UB, Ljunghall S (1988) Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. Am J Epidemiol 1275:1031-1040
12. Pickard AL, Gridley G, Mellemkjae L et al (2002) Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer 958:1611-1617
13. Michels KB, Xue F, Brandt L, Ekbom A (2004) Hyperparathyroidism and subsequent incidence of breast cancer. Int J Cancer 1103:449-451
14. Lowe L, Hansen CM, Senaratne S, Colston KW (2003) Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res 164:99-110
15. Wermers RA, Khosla S, Atkinson EJ et al (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 211:171-177
16. Bolland MJ, Grey AB, Gamble GD, Reid IR (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 903:1525-1530
17. Gaugris S, Heaney RP, Boonen S et al (2005) Vitamin D inadequacy among post-menopausal women: a systematic review. Qjm 989:667-676
18. Manjer J, Janzon L (1999) Covariance of breast cancer incidence with smoking-, oestrogen- and diet-related cancers in pre- and postmenopausal women in Sweden. Med Hypotheses 526:561-568
19. Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 1115:762-771
20. Berglund G, Eriksson KF, Israelsson B et al (1996) Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo Preventive Project. J Intern Med 2396:489-497
21. Manjer J, Berglund G, Bondesson L et al (2000) Breast cancer incidence in relation to smoking cessation. Breast Cancer Res Treat 612:121-129
22. Solberg HE (1984) Monitoring long-term analytical quality by computerized combined Shewart-cusum method. Scand J Clin Lab Invest Suppl 172:43-49
23. Nilsson-Ehle P (2003) Laurells klinisk kemi i praktisk medicin, 8th edn. Studentlitteratur AB, Sweden, p 723
24. Sobin LH, Wittekind C (2002) TNM Classification of Malignant Tumours. 6th edn. John Wiley & Sons, Hoboken, New Jersey
25. Nordin BE, Jm WI, Clifton PM et al (2004) A longitudinal study of bone-related biochemical changes at the menopause. Clin Endocrinol (Oxf) 611:123-130
26. Young MM, Nordin BE (1967) Calcium metabolism and the menopause. Proc R Soc Med 6011 Part 1:1137-1138
27. Ricos C, Alvarez V, Cava F et al (1999) Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 597:491-500
28. Gallagher SK, Johnson LK, Milne DB (1989) Short-term and long-term variability of indices related to nutritional status. I: Ca, Cu, Fe, Mg, and Zn. Clin Chem 353:369-373
29. Prince RL, Dick I, Devine A et al (1995) The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90. J Bone Miner Res 106:835-842
30. Leifsson BG, Ahren B (1996) Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 816:2149-2153
31. Joborn C, Ljunghall S, Larsson K et al (1991) Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement. Clin Endocrinol (Oxf) 345:335-339
32. Cosman F, Shen V, Xie F et al (1993) Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers. Ann Intern Med 1185:337-343
33. Clavel-Chapelon F (2002) Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 865:723-727
34. Lundgren E, Hagstrom EG, Lundin J et al (2002) Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg 268:931-936
35. Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 3524:373-379
36. Garne JP (1996) Invasive breast cancer in Malmö 1961-1992 - an epidemiological study. Dissertation, Lund University, Malmö
37. Nystrom L, Rutqvist LE, Wall S et al (1993) Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 3418851:973-978
38. Welsh J (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 806(Suppl):1721S-1724S
39. Boyapati SM, Shu XO, Jin F et al (2003) Dietary calcium intake and breast cancer risk among Chinese women in Shanghai. Nutr Cancer 461:38-43
40. McCullough ML, Rodriguez C, Diver WR et al (2005) Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 1412:2898-2904
41. Hiatt RA, Krieger N, Lobaugh B et al (1998) Prediagnostic serum vitamin D and breast cancer. J Natl Cancer Inst 906:461-463
42. Bertone-Johnson ER, Chen WY, Holick MF et al (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 148:1991-1997
43. Parodi PW (2005) Dairy product consumption and the risk of breast cancer. J Am Coll Nutr 246(Suppl):556S-568S
44. Dizdar O, Alyamac E (2004) Obesity: an endocrine tumor? Med Hypotheses 635:790-792
45. Kaaks R, Lundin E, Rinaldi S et al (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 134:307-316